Faculty Information - HIRAO Maki | Daito Bunka University

（Last updated : 2025-11-06 23:50:04）

HIRAO Maki

Department Daito Bunka University Faculty of Sports and Health Science Department of Health Science

Daito Bunka University Graduate School Graduate School of Sports and Health Science Sports and Health Science

Job Professor

E-Mail Address

Grants-in-Aid for Scientific Research Reseacher number
10902158

researchmap Researcher code
R000034596

Present specialized field
Sports Medicine, Clinical pharmacy, Sports sciences

Academic background
1.	1990/10～1993/06	A. J. Dimond High School Graduated
2.	1993/09～1994/05	Major in Chemistry College of Liberal Arts Boston University
3.	1994/05～1997/05	Major in Biochemistry College of Liberal Arts Tufts University Graduated Bachelor of Science (B.S.)
4.	1997/05～1998/05	Doctorial Program in Physiology University of California, Davis
5.	1998/06～2003/12	Doctorial Biomolecular Structure and Design University of Washington Finished Ph.D. in Chemistry
Display All（6）

Business career
1.	1996/09 ～ 1996/11	Undergraduate Teaching Assistant Tufts University Cells and Organisms Laboratory
2.	1998/06 ～ 2003/12	University of Washington / Fred Hutchinson Cancer Research Center Clinical Research Division and Public Health Sciences Division
3.	2000/03 ～ 2000/06	ティーチングアシスタントワシントン大学細胞生物学・疾患分子生物学
4.	2009/04 ～ 2011/03	Tokyo Saiseikai Central Hospital
5.	2011/04 ～ 2015/03	Tokyo Saiseikai Central Hospital Department of Medicine
Display All（8）

Academic conference
1.	2013/02 ～	International Myeloma Society
2.	2024/05 ～	Japan Society of Golf Sciences

Books and Papers
1.	Papers	Association of health literacy with quality of life and health outcomes among school-age children in Japan: A cross-sectional study PLOS ONE 20 (5),pp.e0324456 (Co-authored) 2025/05/20
2.	Papers	Questionnaire survey on diversity, equity, and inclusion (DE&I) by the Diversity Promotion Committee of the Japanese Society of Myeloma in 2023,pp.47-52 (Co-authored) 2024/12/25
3.	Papers	Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells Pharmaceuticals 16,pp.1367-1382 (Co-authored) 2023/09
4.	Papers	Factors Associated with Refraining from Health Checkups during the COVID-19 Pandemic in Japan Healthcare 11 (17),pp.2385-2397 (Co-authored) 2023/08
5.	Papers	Novel Aldosterone Antagonists in Hypertension and Diabetic Kidney Disease Japanese Pharmacology & Therapeutics,pp.1071-1087 (Co-authored) 2023/07
Display All（22）

Academic conference presentation
1.	2025/10/05	Digitally Vulnerable Groups: Promoting Inclusive Digital Health Literacy
2.	2024/05	Result of the questionnaire survey on diversity, equity, and inclusion (DE & I) by the diversity promotion committee of the Japanese Society of Myeloma
3.	2020/07	A Hereditary bleeding disorder caused by a novel homozygous mutation of thrombomodulin gene (ISTH Congress（Milan, Italy）)
4.	2018/12	Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma (ASH 60th Annual Meeting（San Diego, USA）)
5.	2018/07	Identification of clonal evolution of CSF3R-mutated chronic neutrophilic leukemia using mutational screens of SETBP1, ASXL1 and SRSF2 (9th JSH International Symposium（Kyoto, Japan）)
Display All（12）

Research topic, funded research, and Grants-in-Aid for Scientific Research
1.	1996/06 ～ 1996/08	Localization of alliin lyase mRNA in the garlic clove by in situ hybridization with digoxigenin riboprobes Joint Research inside the organization

Awards
1.	1996/05	Howard Hughes Medical Institute Undergraduate Research Fellow（選抜）（Tufts University）
2.	1997/05	High Honors in Thesis（優等）B.S. Biochemistry, Tufts University (Localization of alliin lyase mRNA in the garlic clove by in situ hybridization with digoxigenin labeled riboprobes)